share_log

Coloplast Agrees to Buy Atos Medical From PAI Partners for EUR2.16 Bln

Coloplast Agrees to Buy Atos Medical From PAI Partners for EUR2.16 Bln

Colplast同意以21.6亿欧元从PAI Partners手中收购Atos Medical
Dow Jones Newswires ·  2021/11/08 02:40

By Dominic Chopping

多米尼克·切普著

Danish medical-device and services provider Coloplast AS said Monday that it has agreed to acquire Atos Medical from French private-equity firm PAI Partners in a deal worth 2.16 billion euros ($2.5 billion).

丹麦医疗器械和服务提供商Colopast as周一表示，已同意从法国私募股权公司PAI Partners手中收购Atos Medical，交易价值21.6亿欧元(合25亿美元)。

Atos Medical supplies specialist medical equipment for laryngectomy--the removal of the larynx--and related care for people living with a neck stoma, an opening in the neck that allows patients to breathe.

阿托斯医疗公司为喉部切除(即切除喉部)提供专门的医疗设备，并为颈部吻合口患者提供相关护理。颈部吻合口是颈部的一个开口，可以让患者呼吸。

"Following the expected acquisition, Coloplast gains access to a new chronic care segment to be run as a separate strategic business unit operating on shared Coloplast infrastructure," Coloplast said.

Colopast说：“在预期的收购之后，Colopast将获得一个新的慢性护理部门，该部门将作为一个独立的战略业务部门运营，在共享的Colopast基础设施上运营。”

Headquartered in Sweden, Atos Medical serves customers in around 90 countries and has around 1,150 employees and a direct presence in 30 countries. For the year ended Dec. 31, Atos Medical delivered pro forma revenue of 2.2 billion Swedish kronor ($256.4 million) and adjusted pro forma earnings before interest, tax, depreciation and amortization of SEK800 million.

Atos Medical总部设在瑞典，为大约90个国家和地区的客户提供服务，拥有约1150名员工，在30个国家和地区设有直接分支机构。在截至12月31日的一年中，Atos Medical实现了22亿瑞典克朗(合2.564亿美元)的预计收入，调整后的预计利息、税项、折旧和摊销前收益(EBITDA)为8亿瑞典克朗。

Write to Dominic Chopping at dominic.chopping@wsj.com

写信给多米尼克·切普林，电子邮件：domic.choping@wsj.com

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发